Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
American Journal of Hematology|May 1, 1992
Bone marrow necrosis in lymphoma studied by magnetic resonance imagingD E Weissman, W G Negendank, A M al-Katib, et al.
Anti-Cancer Drugs|July 27, 2000
Effects of combretastatin A-4 prodrug against a panel of malignant human B-lymphoid cell linesS M Nabha, N R Wall, R M Mohammad, et al.
Biochemical and Biophysical Research Communications|December 3, 1999
Modulation of cIAP-1 by novel antitubulin agents when combined with bryostatin 1 results in increased apoptosis in the human early pre-B acute lymphoblastic leukemia cell line RehN R Wall, R M Mohammad, S M Nabha, et al.
Investigational New Drugs|September 20, 2001
Phase II study of bryostatin 1 in patients with relapsed multiple myelomaM L Varterasian, P A Pemberton, K Hulburd, et al.
Cancer Investigation|May 16, 2000
Non-Hodgkin's lymphoma: an analysis of the Metropolitan Detroit SEER databaseM L Varterasian, J J Graff, R K Severson, et al.
Cancer Letters|June 10, 1998
Similarities between the sensitivity to 2-chlorodeoxyadenosine of lymphocytes from CLL patients and bryostatin 1-treated WSU-CLL cells: an infrared spectroscopic studyK Z Liu, C P Schultz, R M Mohammad, et al.
International Journal of Oncology|April 14, 1999
Treatment of a de novo fludarabine resistant-CLL xenograft model with bryostatin 1 followed by fludarabineR M Mohammad, C Limvarapuss, N Hamdy, et al.
International Journal of Molecular Medicine|March 17, 2000
Bryostatin 1-induced modulation of nucleoside transporters and 2-chlorodeoxyadenosine influx in WSU-CLL cellsF W Beck, A M Al-Katib, I Ahmad, et al.
Leukemia|August 18, 1999
Infrared spectroscopic study of bryostatin 1-induced membrane alterations in a B-CLL cell lineK Z Liu, C P Schultz, J B Johnston, et al.
Anti-Cancer Drugs|March 29, 2001
Evaluation of combretastatin A-4 prodrug in a non-Hodgkin's lymphoma xenograft model: preclinical efficacyS M Nabha, R M Mohammad, N R Wall, et al.
Pageof 3